or Try an Advanced Search...

    ETF Components for CNBS - Amplify Seymour Cannabis ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    TLRY D 1.71 6.18
    IIPR B -0.17 5.30
    MAPS D -1.85 4.12
    GRWG F 0.91 3.22
    SSIC A 0.61 2.77
    SNDL B 3.08 1.71
    REFI B 0.58 1.42
    OGI D 0.00 0.98
    HYFM F -2.94 0.47
    JAZZ F 1.89 0.19
    CARA F -2.24 0.13

    Represented by ETF Holdings

    Keywords: Cannabis Entheogens Euphoriants Medicinal Plants Medicine Aeroponics Biopharmaceutical Cannabis Products Cannabis Smoking Chronic Pain Drugs Health Sciences Herbalism Hydroculture Hydroponics Medical Cannabis Pain Plants Private Equity Psychoactive Drugs
    Industries: Drug Manufacturers - Specialty & Generic Biotechnology Conglomerates Farm & Heavy Construction Machinery Home Improvement Retail REIT - Industrial REIT - Mortgage

    Recent News for Amplify Seymour Cannabis ETF & its Holdings

    Date Stock Title
    Apr 26 OGI Are Medical Stocks Lagging OrganiGram (OGI) This Year?
    Apr 26 SNDL SNDL to Announce First Quarter 2024 Financial Results on May 9, 2024
    Apr 25 TLRY Tilray Brands Celebrates Big Wins at the Craft Brewer’s Conference and 2024 World Beer Cup, the Most Prestigious Beer Competition in the World
    Apr 25 CNBS Cannabis stocks outperform as pressure mounts on DEA to reschedule marijuana
    Apr 25 JAZZ Ardelyx (ARDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
    Apr 25 TLRY Tilray Brands Celebrates Epic 420 Weekend With Over 20,000 Fans Across the U.S.
    Apr 25 GRWG GrowGeneration Announces Change to Board of Directors
    Apr 25 TLRY Sweetwater Brewing Unveils Modern Rebrand
    Apr 24 IIPR Innovative Industrial Properties (IIPR) Outperforms Broader Market: What You Need to Know
    Apr 24 JAZZ Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024
    Apr 24 JAZZ Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
    Apr 24 TLRY Good Supply Cannabis Introduces New Signature ‘Bud Squad’ Products
    Apr 24 TLRY 3 Reasons Tilray Brands Investors Shouldn't Assume U.S. Marijuana Legalization Would Fix the Stock's Problems
    Apr 24 JAZZ 3 No-Brainer Stocks to Buy With $300 Right Now
    Apr 23 MAPS After The 4/20 Smoke Clears: What Do The Billions Spent On Cannabis Say About Sales In Key States?
    Apr 23 SNDL Peering Into SNDL's Recent Short Interest
    Apr 23 GRWG GrowGeneration Schedules First Quarter 2024 Earnings Release Conference Call for May 8, 2024
    Apr 22 IIPR Innovative Industrial Properties to Report 2024 First Quarter Results
    Apr 22 JAZZ A Closer Look At Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) Uninspiring ROE
    Apr 21 OGI Organigram Is My Favorite Cannabis Stock Again
    The investment seeks to provide investors capital appreciation. The fund will invest at least 80% of its net assets (including investment borrowings) in the securities of companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem. It is an actively managed ETF that seeks to provide investment exposure to global companies principally engaged in the emerging cannabis and hemp ecosystem across one of three classifications. The fund is non-diversified.
    Exchange Traded Funds Cannabis Hemp
    Back to the Main CNBS Page...